CD74 interacts with APP and suppresses the production of A

Shuji Matsuda, Yukiko Matsuda, Luciano D'Adamio

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background. Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of amyloid (A) peptides. A is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing by -secretase and -secretase. Results. Here, we show that CD74, the invariant chain of class II major histocompatibility complex, interacts with APP and serves as a negative regulator of A. CD74 resembles other APP interacters such as BRI2 and BRI3, since all of them reduce the level of A. However, unlike BRIs, CD74 does not reduce the secretion of sAPP or sAPP. Interestingly, in HeLa cells, over expression of CD74 steers APP, but not Notch, to large vacuoles created by CD74. Conclusion. Taken together, we propose that CD74 inhibits A production by interacting with and derailing normal trafficking of APP.

Original languageEnglish (US)
Article number41
JournalMolecular Neurodegeneration
Volume4
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Amyloid beta-Protein Precursor
Amyloid Precursor Protein Secretases
Amyloid Plaques
Vacuoles
Major Histocompatibility Complex
HeLa Cells
Amyloid
Alzheimer Disease
Peptides

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Clinical Neurology
  • Molecular Biology

Cite this

CD74 interacts with APP and suppresses the production of A. / Matsuda, Shuji; Matsuda, Yukiko; D'Adamio, Luciano.

In: Molecular Neurodegeneration, Vol. 4, No. 1, 41, 2009.

Research output: Contribution to journalArticle

Matsuda, Shuji ; Matsuda, Yukiko ; D'Adamio, Luciano. / CD74 interacts with APP and suppresses the production of A. In: Molecular Neurodegeneration. 2009 ; Vol. 4, No. 1.
@article{4053fb5892c24691a2c598146b576128,
title = "CD74 interacts with APP and suppresses the production of A",
abstract = "Background. Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of amyloid (A) peptides. A is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing by -secretase and -secretase. Results. Here, we show that CD74, the invariant chain of class II major histocompatibility complex, interacts with APP and serves as a negative regulator of A. CD74 resembles other APP interacters such as BRI2 and BRI3, since all of them reduce the level of A. However, unlike BRIs, CD74 does not reduce the secretion of sAPP or sAPP. Interestingly, in HeLa cells, over expression of CD74 steers APP, but not Notch, to large vacuoles created by CD74. Conclusion. Taken together, we propose that CD74 inhibits A production by interacting with and derailing normal trafficking of APP.",
author = "Shuji Matsuda and Yukiko Matsuda and Luciano D'Adamio",
year = "2009",
doi = "10.1186/1750-1326-4-41",
language = "English (US)",
volume = "4",
journal = "Molecular Neurodegeneration",
issn = "1750-1326",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - CD74 interacts with APP and suppresses the production of A

AU - Matsuda, Shuji

AU - Matsuda, Yukiko

AU - D'Adamio, Luciano

PY - 2009

Y1 - 2009

N2 - Background. Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of amyloid (A) peptides. A is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing by -secretase and -secretase. Results. Here, we show that CD74, the invariant chain of class II major histocompatibility complex, interacts with APP and serves as a negative regulator of A. CD74 resembles other APP interacters such as BRI2 and BRI3, since all of them reduce the level of A. However, unlike BRIs, CD74 does not reduce the secretion of sAPP or sAPP. Interestingly, in HeLa cells, over expression of CD74 steers APP, but not Notch, to large vacuoles created by CD74. Conclusion. Taken together, we propose that CD74 inhibits A production by interacting with and derailing normal trafficking of APP.

AB - Background. Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of amyloid (A) peptides. A is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing by -secretase and -secretase. Results. Here, we show that CD74, the invariant chain of class II major histocompatibility complex, interacts with APP and serves as a negative regulator of A. CD74 resembles other APP interacters such as BRI2 and BRI3, since all of them reduce the level of A. However, unlike BRIs, CD74 does not reduce the secretion of sAPP or sAPP. Interestingly, in HeLa cells, over expression of CD74 steers APP, but not Notch, to large vacuoles created by CD74. Conclusion. Taken together, we propose that CD74 inhibits A production by interacting with and derailing normal trafficking of APP.

UR - http://www.scopus.com/inward/record.url?scp=70450233614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450233614&partnerID=8YFLogxK

U2 - 10.1186/1750-1326-4-41

DO - 10.1186/1750-1326-4-41

M3 - Article

VL - 4

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

SN - 1750-1326

IS - 1

M1 - 41

ER -